CASE REPORT
Accepted on 28 Jan 2025
Ensartinib as a neoadjuvant therapy for stage IIIA non-small cell lung cancer patients with EML4-ALK fusion: a case report and literature review
doi 10.3389/fonc.2025.1474997
1,549
Total downloads
6,290
Total views and downloads
You will be redirected to our submission process.
CASE REPORT
Accepted on 28 Jan 2025
ORIGINAL RESEARCH
Published on 24 Jan 2025
ORIGINAL RESEARCH
Accepted on 20 Jan 2025
ORIGINAL RESEARCH
Published on 13 Jan 2025
ORIGINAL RESEARCH
Published on 07 Jan 2025
ORIGINAL RESEARCH
Published on 04 Dec 2024
ORIGINAL RESEARCH
Published on 06 Nov 2024
ORIGINAL RESEARCH
Published on 14 Oct 2024
ORIGINAL RESEARCH
Published on 08 Oct 2024
ORIGINAL RESEARCH
Published on 19 Sep 2024
ORIGINAL RESEARCH
Published on 12 Aug 2024
ORIGINAL RESEARCH
Published on 07 Aug 2024